NewAmsterdam Pharma Co NV (NAMS)
21.43
-0.43
(-1.97%)
USD |
NASDAQ |
May 10, 16:00
21.44
+0.02
(+0.07%)
After-Hours: 20:00
NewAmsterdam Pharma Price to Book Value: 6.633 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 6.633 |
| May 09, 2024 | 6.766 |
| May 08, 2024 | 6.745 |
| May 07, 2024 | 6.872 |
| May 06, 2024 | 6.766 |
| May 03, 2024 | 6.754 |
| May 02, 2024 | 6.986 |
| May 01, 2024 | 6.800 |
| April 30, 2024 | 6.751 |
| April 29, 2024 | 6.704 |
| April 26, 2024 | 6.807 |
| April 25, 2024 | 6.636 |
| April 24, 2024 | 6.748 |
| April 23, 2024 | 6.639 |
| April 22, 2024 | 6.262 |
| April 19, 2024 | 6.169 |
| April 18, 2024 | 6.017 |
| April 17, 2024 | 6.206 |
| April 16, 2024 | 6.036 |
| April 15, 2024 | 6.110 |
| April 12, 2024 | 6.098 |
| April 11, 2024 | 6.169 |
| April 10, 2024 | 5.912 |
| April 09, 2024 | 5.866 |
| April 08, 2024 | 6.070 |
| Date | Value |
|---|---|
| April 05, 2024 | 6.438 |
| April 04, 2024 | 6.627 |
| April 03, 2024 | 6.844 |
| April 02, 2024 | 6.624 |
| April 01, 2024 | 6.615 |
| March 28, 2024 | 7.320 |
| March 27, 2024 | 7.026 |
| March 26, 2024 | 7.033 |
| March 25, 2024 | 6.952 |
| March 22, 2024 | 6.893 |
| March 21, 2024 | 6.949 |
| March 20, 2024 | 6.853 |
| March 19, 2024 | 6.825 |
| March 18, 2024 | 6.822 |
| March 15, 2024 | 6.819 |
| March 14, 2024 | 6.788 |
| March 13, 2024 | 6.903 |
| March 12, 2024 | 7.252 |
| March 11, 2024 | 6.482 |
| March 08, 2024 | 6.491 |
| March 07, 2024 | 6.475 |
| March 06, 2024 | 6.822 |
| March 05, 2024 | 6.893 |
| March 04, 2024 | 7.135 |
| March 01, 2024 | 7.286 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.073
Minimum
Oct 25 2023
7.500
Maximum
Feb 27 2024
3.281
Average
2.471
Median
Mar 10 2023
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.774 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7009 |
| Theriva Biologics Inc | 0.2004 |
| Oragenics Inc | 5.233 |
Price to Book Value Related Metrics
| PS Ratio | 124.96 |
| Price | 21.43 |
| Earnings Yield | -10.03% |
| Market Cap | 1.913B |